Skip to content
healthcare.dev

Lisdexamfetamine Dimesylate

NDC 42291-037, Lisdexamfetamine, capsule, from AvKARE.

Product NDC
42291-037
Status
Listed
Labeler
AvKARE
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202830
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-037 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE30 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
42291-037-904229100379090 CAPSULE in 1 BOTTLE (42291-037-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/36c40404-fe94-6fb7-e063-6394a90a2657

Use it

Look up 42291-037 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-037 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-037. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.